Concepedia

M. Cianfrocca

MC

Statistics

Publications

4

Citations

258

H-Index

4

Active since

2001

Affiliations

Fox Chase Cancer Center(Current)

M. Cianfrocca is an author at Fox Chase Cancer Center specializing in medicine, breast oncology, and cancer pharmacology.

Publications per year

2001–2006

4

Publications

4

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

M. Cianfrocca, Kathryn A. Kimmel, James M. Gallo et al. · British Journal of Cancer · 2006 · 177 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

M. Cianfrocca, W.J. Gradishar · Breast Diseases A Year Book Quarterly · 2006 · 45 citations

Medicine, Oncology, Breast Oncology +6

A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients

Quincy S. Chu, Laura H. Goldstein, Nicholas Murray et al. · Journal of Clinical Oncology · 2005 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +17

Treatment of Kaposi's sarcoma.

von Roenn Jh, M. Cianfrocca · PubMed · 2001 · 10 citations

Medicine, Oncology, Immunopathology +4

1–4 of 4